Search for: "Par Pharmaceutical"
Results 61 - 80
of 303
Sort by Relevance
|
Sort by Date
17 Jan 2018, 1:25 pm
Novartis Pharmaceuticals Corporation, S233898).Le devoir de diligence est une des conditions centrales de l'obligation de réparer un dommage en responsabilité civile. [read post]
14 Jan 2018, 6:34 am
Novartis Pharmaceuticals Corporation, S233898).Exigences en matière d'étiquetages et notices, ici de médicaments et de dispositifs médicaux Le droit des états, ici californien, protège substantiellement les consommateurs de médicaments des dangers posés par des étiquetages et des notices faux, trompeurs ou inadéquats. [read post]
13 Jan 2018, 8:00 pm
Il peut être recherché à cet égard en responsabilité même par un demandeur à qui le générique a été prescrit. [read post]
4 Nov 2017, 5:47 am
The case concerned the use of ribavirin for the manufacturer of a pharmaceutical composition for treating a specific sub-group (the G1N-subgroup) of HCV patients suffering with chronic hepatitis. [read post]
1 Nov 2017, 4:00 am
TD Canada Trust, 2017 SCC 51 [1] A pharmaceutical company was the victim of a fraudulent cheque scheme implemented by one of its employees. [read post]
24 Oct 2017, 4:15 am
See Par Pharmaceutical, Inc. v. [read post]
29 Sep 2017, 12:26 pm
IPOs and offerings of small pharmaceutical companies are incredibly risky – on par with the risks of penny stocks. [read post]
25 Jul 2017, 8:28 am
The MDL dropped to $302 billion, on par with the historical semiannual average. [read post]
21 Jul 2017, 8:33 am
" Par Pharm., 773 F.3d at 1195-96. [read post]
17 Jul 2017, 9:41 am
Par Pharm., Inc. v. [read post]
9 May 2017, 9:59 pm
The decision arose out of a patent dispute between Plaintiffs Par Pharmaceutical, Inc., Par Sterile Products, LLC,... [read post]
26 Apr 2017, 7:24 am
.'" Par Pharmaceutical, Inc. et al v. [read post]
13 Mar 2017, 9:30 am
At the same time, this is also par for the course. [read post]
8 Nov 2016, 11:53 pm
Among the generic drug companies experiencing this share price decline were Allergan, Teva Pharmaceuticals, and Endo Pharmaceuticals. [read post]
21 Feb 2016, 8:07 pm
Par Pharmaceutical, Inc. 1:15-cv-00886; filed October 2, 2015 in the District Court of Delaware Infringement of U.S. [read post]
26 Jan 2016, 11:23 am
**As one small footnote, Ampyra is not a disease-modifying treatment for MS, in contrast to Copaxone or Tecfidera.link to BNA report: http://www.bna.com/acorda-par-settle-n57982066522/ [read post]
29 Nov 2015, 9:54 pm
• Defendants: Amneal Pharmaceuticals LLC; Amneal Pharmaceuticals of New York LLC; Par Pharmaceutical, Inc. [read post]
1 Nov 2015, 9:57 pm
Par Pharmaceutical Inc. et al. 1:15-cv-00679; filed August 3, 2015 in the District Court of Delaware • Plaintiffs: Janssen Biotech Inc.; Janssen Oncology Inc.; Janssen Research & Development LLC • Defendants: Amneal Pharmaceuticals LLC; Amneal Pharmaceuticals of New York LLC; Par Pharmaceutical Inc.; Par Pharmaceutical Companies Inc. [read post]
12 Sep 2015, 8:01 am
Robinson in Par Pharmaceutical, Inc., et al. v. [read post]
21 Aug 2015, 11:16 am
Bloomberg reports on an unfavorable result for Takeda's drug Velcade .Link: http://www.bloomberg.com/news/articles/2015-08-20/takeda-velcade-patent-overturned-in-win-for-generic-drug-makersRecall the Federal Circuit has stated: A party must … meet a high standard in order to rely on inherency to establish the existence of a claim limitation in the prior art in an obviousness analysis—the limitation at issue necessarily must be present, or the natural result of the combination… [read post]
